Cytarabine

Alternative names

ACTR, AI838772, AIB-1, AIS, ANDR_HUMAN, AR, AR8, AW493413, Amplified in breast cancer 1, Amplified in breast cancer 1 protein, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, BCC7, CAGH 16, CAR, CAR BETA, CARA, CBP-interacting protein, CTG 26, Car 1, Cellular tumor antigen p53, Class E basic helix-loop-helix protein 42, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, DHTR, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 2.1.1.45, FLJ11090, FLJ92943, HUMARA, HYSP1, HsT422, IMD42, KAT13B / AIB1, KD, Kennedy disease (KD), LFS1, MB67, MGC104252, MGC112732, MGC129539, MGC141848, MGC88736, MGC97144, Mutant tumor protein 53, NCOA3_HUMAN, NR1F3, NR1I3_HUMAN, NR3C4, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor coactivator 3, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), OTTHUMP00000162195, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, P53_HUMAN, Phosphoprotein p53, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RORG_HUMAN, RP24-311F12.2, RZR GAMMA, RZRG, Receptor-associated coactivator 3, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, SBMA, SCAN1, SMAX1, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid receptor coactivator protein 3, TFM, TMS, TNRC 14, TNRC16, TOR, TRP53, TS, TSase, TYDP, TYDP1_HUMAN, TYMS protein, TYSY_HUMAN, Testicular Feminization (TFM), Thymidylate synthase, Thymidylate synthetase, Thyroid hormone receptor activator molecule 1, Tp53, Transformation related protein 53, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyms, Tyms thymidylate synthetase, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, androgen receptor splice variant 4b, bHLHe42, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, d TMP synthase, orphan nuclear hormone receptor, p53 tumor suppressor, pCIP, tumor antigen p55